Structure of Human Methionine Aminopeptidase-2 Complexed with Fumagillin

+ See all authors and affiliations

Science  13 Nov 1998:
Vol. 282, Issue 5392, pp. 1324-1327
DOI: 10.1126/science.282.5392.1324

You are currently viewing the abstract.

View Full Text

Via your Institution

Log in through your institution

Log in through your institution


The fungal metabolite fumagillin suppresses the formation of new blood vessels, and a fumagillin analog is currently in clinical trials as an anticancer agent. The molecular target of fumagillin is methionine aminopeptidase-2 (MetAP-2). A 1.8 Å resolution crystal structure of free and inhibited human MetAP-2 shows a covalent bond formed between a reactive epoxide of fumagillin and histidine-231 in the active site of MetAP-2. Extensive hydrophobic and water-mediated polar interactions with other parts of fumagillin provide additional affinity. Fumagillin-based drugs inhibit MetAP-2 but not MetAP-1, and the three-dimensional structure also indicates the likely determinants of this specificity. The structural basis for fumagillin's potency and specificity forms the starting point for structure-based drug design.

  • * To whom correspondence should be addressed. E-mail: jcc12{at}

View Full Text

Related Content